Blocking Enzyme Caspase-2 May Increase Risk of Liver Cancer, Study Finds

Researchers at the University of Adelaide found that a potential treatment for fatty liver could actually cause cancer. Until now, blocking the enzyme caspase-2 was thought to be beneficial for reversing nonalcoholic fatty liver disease. But new research published in Science Advances shows that blocking this enzyme also increases the risk of chronic liver injury, scarring, and cancer with age. Dr. Gurwant S. Lamba, director of gastroenterology and hepatology at Delhi-based Sri Balaji Action Medical Institute, explains the need for the enzyme caspase-2 and the risk of its deficiency. He also shares some natural ways to reverse fatty liver in the early stages. Why the study raises concern?